Summary: FDA Center for Devices and Radiological Health (CDRH) director Jeff Shuren announced his retirement after a long career starting in 1998 and becoming CDRH director in 2009. Michelle Tarver, PhD, MD, will serve as interim director. Shuren will help find his permanent replacement and will remain as center director emeritus.
Key Takeaways:
- Retirement Announcement: Jeff Shuren, director of FDA’s CDRH, will retire, with Michelle Tarver, PhD, MD, stepping in as interim director.
- Career Overview: Shuren has been with the FDA since 1998 and has served as CDRH director since 2009.
- Transition Plan: Shuren will assist in finding a permanent replacement and will remain as center director emeritus.
Retirement Announcement
FDA Center for Devices and Radiological Health (CDRH) director Jeff Shuren announced his plans to retire, according to a report in Mass Device.
Leadership Transition
In an email that was viewed by the publication, Shuren will step down and be replaced by Michelle Tarver, PhD, MD, in an interim role. Shuren began his career with the FDA in 1998 and rose to his position as CDRH director in 2009.
Shuren held various policy and planning positions within FDA from 1998 to 2009, including acting deputy commissioner for policy, planning, and budget; associate commissioner for policy and planning; special counsel to the principal deputy commissioner; assistant commissioner for policy; and medical officer in the Office of Policy.
Interim Director
Shuren will reportedly help CDRH find his permanent replacement and will remain as the center director emeritus.
Tarver joined CDRH in 2009 and most recently served as deputy center director for transformation.
